Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Cancers|January 8, 2023
Estimated Costs of the Ipilimumab-Nivolumab Therapy and Related Adverse Events in Metastatic MelanomaBianca Gautron Moura, Camille L Gerard, Nathalie Testart, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 22, 2023
Development of an eHealth-enhanced model of care for the monitoring and management of immune-related adverse events in patients treated with immune checkpoint inhibitorsAndré Manuel da Silva Lopes, Sara Colomer-Lahiguera, Célia Darnac, et al.Journal for Immunotherapy of Cancer|February 20, 2021
Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and GermanyJulia Maria Ressler, Matthias Karasek, Lukas Koch, et al.JMIR Research Protocols|October 18, 2023
Testing a Model of Care for Patients on Immune Checkpoint Inhibitors Based on Electronic Patient-Reported Outcomes: Protocol for a Randomized Phase II Controlled TrialAndré Manuel da Silva Lopes, Sara Colomer-Lahiguera, Célia Darnac, et al.Cancers|January 8, 2023
Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT StudyCarole Bandiera, Isabella Locatelli, Perrine Courlet, et al.Contemporary Clinical Trials|August 12, 2022
The Sleep, Cancer and Rest (SleepCaRe) Trial: Rationale and design of a randomized, controlled trial of cognitive behavioral and bright light therapy for insomnia and fatigue in women with breast cancer receiving chemotherapyJordan Maccora, Sheila N Garland, Maria Ftanou, et al.Plos One|June 7, 2024
A pharmacist-led interprofessional medication adherence program improved adherence to oral anticancer therapies: The OpTAT randomized controlled trialCarole Bandiera, Evelina Cardoso, Isabella Locatelli, et al.Revue Medicale Suisse|January 22, 2020
[Advances in Oncology 2019]Anastasia Vernadou, Nabila Ferahta, Nuria Mederos, et al.European Journal of Cancer (Oxford, England : 1990)|September 18, 2021
Patient-reported outcomes for monitoring symptomatic toxicities in cancer patients treated with immune-checkpoint inhibitors: A Delphi studyAndré Manuel Da Silva Lopes, Sara Colomer-Lahiguera, Nuria Mederos Alfonso, et al.Psycho-Oncology|March 22, 2026
A Randomized Controlled Trial: Evaluating the Sleep, Cancer and Rest (SleepCaRe) Trial to Improve Health-Related Quality of Life in Women Undergoing Chemotherapy for Breast CancerRebecca Wallace, Marliese Alexander, Daphne Day, et al.Pageof 3